Eptifibatide (acetate)

Eptifibatide acetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].

Product Specifications

CAS Number

[881997-86-0]

UNSPSC

12352209

Hazard Statement

H302, H315, H319, H335

Target

Integrin

Type

Peptides

Related Pathways

Cytoskeleton

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Purity

99.84

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(O)=O)NC(CNC([C@H](CCCCNC(N)=N)N3)=O)=O)=O)N4CCC[C@]4(C(N[C@H](C(N)=O)CSSCCC3=O)=O)[H].CC(O)=O.[x]

Molecular Formula

C35H49N11O9S2.xC2H4O2

Molecular Weight

831.96 (free base)

Precautions

H302, H315, H319, H335

References & Citations

[1]Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42 (8) :703-20.